发明公开
EP2566566A1 ADULT STEM CELLS/PROGENITOR CELLS AND STEM CELL PROTEINS FOR TREATMENT OF EYE INJURIES AND DISEASES
有权
成体干细胞/祖细胞干细胞和蛋白用于治疗眼睛的伤害和疾病
- 专利标题： ADULT STEM CELLS/PROGENITOR CELLS AND STEM CELL PROTEINS FOR TREATMENT OF EYE INJURIES AND DISEASES
- 专利标题（中）： 成体干细胞/祖细胞干细胞和蛋白用于治疗眼睛的伤害和疾病
-
申请号： EP11777695.5申请日： 2011-05-03
-
公开(公告)号： EP2566566A1公开(公告)日： 2013-03-13
- 发明人: PROCKOP, Darwin, J. , OH, Joo, Youn , RODDY, Gavin, W. , ROSA, Robert , BERKOWITZ, Barry A.
- 申请人： The Texas A&M University System , Scott & White Healthcare , Temple Therapeutics, LLC
- 申请人地址： Mail Stop 3369 800 Raymond Stotzer Parkway Suite 300 College Station, TX 77845 US
- 专利权人： The Texas A&M University System,Scott & White Healthcare,Temple Therapeutics, LLC
- 当前专利权人： The Texas A&M University System,Scott & White Healthcare,Temple Therapeutics, LLC
- 当前专利权人地址： Mail Stop 3369 800 Raymond Stotzer Parkway Suite 300 College Station, TX 77845 US
- 代理机构： Walcher, Armin
- 优先权： US330735P 20100503; US201161464172P 20110228
- 国际公布： WO2011139357 20111110
- 主分类号： A61M31/00
- IPC分类号： A61M31/00
摘要：
The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, anti-apoptotic, immune modulatory and anti-tumorigenic properties. The invention includes administration of TSG-6, STC-1, or a combination thereof to the ocular as a treatment for an ocular disease, disorder or condition in a mammal.
公开/授权文献
信息查询
